MENU
TNXP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Tonix Pharmaceuticals Holding (TNXP) Ownership - Who owns Tonix Pharmaceuticals Holding?

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering... Show more

Profile

Industry
Pharmaceuticals Other
Address
26 Main Street
Phone
+1 862 799-8599
Employees
103
Web
https://www.tonixpharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
129.51M
P/E Ratio
N/A
Total Cash
98.78M
Projected Growth
N/A
Total Debt
8.12M
Revenue
10.09M
Risk (Beta)
1.22
Dividend Yield
N/A
Total Cash/Share
14.36
Total Debt/Equity
0.58
Revenue/Share
13.71 USD as % of share price

Fundamentals

TNXP
Capitalization
130M
P/E Ratio
N/A
Risk (Beta)
1.22
Dividend Yield
N/A
Total Cash
98.8M
Total Cash/Share
14.36
Total Debt
8.12M
Total Debt/Equity
0.58
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
13.71%
Revenue
10.1M
ROE
N/A
Book Value
140M
P/B Ratio
0.93
Cash Flow
N/A
Earnings
-17.66K
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
6.50
Current Revenue Per Employee
31876.54
Dividends Per Share - Security
N/A
EBITDA
-71.73M
Float
N/A
Float - Current
N/A
Gross Income Margin
54.18
Revenue To Assets
-81.95
Shares Held By Institutions
5.27M
Shares Outstanding - Current
6.88M
Total Liabilities
23.3M
Total Volume MTD
N/A
Value
1
Gain YTD
-42.905
View a ticker or compare two or three
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company which engages in developing and manufacturing pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
26 Main Street
Phone
+1 862 799-8599
Employees
103
Web
https://www.tonixpharma.com